identified that CXCL9 serum concentrations correlated significantly with tumor stages, nodal stages, overall stages, 5‐year overall survival and DFS in NPC patients, as well as EBV DNA load. The gene discussed is CXCL9; the disease is nasopharyngeal carcinoma.